These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Phase I study of busulfan, cyclophosphamide, and timed sequential escalating doses of cytarabine followed by bone marrow transplantation. Geller RB, Myers S, Devine S, Larson RA, Williams SF, Park CL, O'Toole K, Chandler C, Topper RL. Bone Marrow Transplant; 1992 Jan; 9(1):41-7. PubMed ID: 1543948 [Abstract] [Full Text] [Related]
16. Octreotide versus loperamide in the treatment of fluorouracil-induced diarrhea: a randomized trial. Cascinu S, Fedeli A, Fedeli SL, Catalano G. J Clin Oncol; 1993 Jan; 11(1):148-51. PubMed ID: 8418225 [Abstract] [Full Text] [Related]
17. Octreotide in the management of diarrhea induced by graft versus host disease. Ippoliti C, Neumann J. Oncol Nurs Forum; 1998 Jun; 25(5):873-8. PubMed ID: 9644703 [Abstract] [Full Text] [Related]
19. Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma. Topkan E, Karaoglu A. Oncology; 2006 Jun; 71(5-6):354-60. PubMed ID: 17873499 [Abstract] [Full Text] [Related]
20. Octreotide in the treatment of severe chemotherapy-induced diarrhea. Zidan J, Haim N, Beny A, Stein M, Gez E, Kuten A. Ann Oncol; 2001 Feb; 12(2):227-9. PubMed ID: 11300329 [Abstract] [Full Text] [Related] Page: [Next] [New Search]